ModelEdge

Citius Pharmaceuticals Inc.
CTXR
Filing Type10-K
Filing Date12/22/2025
Updated12/23/25, 2:21 PM

Filing

10-K
Earnings Release

Exhibits

10-KFY 2025
EX-4.31FORM OF WARRANT ISSUED ON DECEMBER 2, 2025
EX-10.38AMENDMENT TO PROMISSORY NOTE, DATED SEPTEMBER 10, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND CITIUS PHARMACEUTICALS, INC
EX-10.39SECOND AMENDMENT TO PROMISSORY NOTE, DATED DECEMBER 10, 2025, BY AND BETWEEN CITIUS ONCOLOGY, INC. AND CITIUS PHARMACEUTICALS, INC
EX-10.45AMENDMENT NO. 1 TO UNSECURED PROMISSORY NOTE ISSUED TO PAGODA RESOURCES, INC., DATED DECEMBER 2, 2025
EX-10.48FIRST AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT BY AND BETWEEN MYRON HOLUBIAK AND CITIUS PHARMACEUTICALS, INC., EXECUTED SEPTEMBER 25, 2024, EFFECTIVE MAY 31, 2024
EX-10.49SECOND AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT BY AND BETWEEN MYRON HOLUBIAK AND CITIUS PHARMACEUTICALS, INC., EXECUTED DECEMBER 23, 2025, EFFECTIVE OCTOBER 31, 2025
EX-23.1CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
EX-31.1CERTIFICATION
EX-31.2CERTIFICATION
EX-32.1CERTIFICATION